Business Description
Tenaya Therapeutics Inc
NAICS : 541714
SIC : 2833
ISIN : US87990A1060
Description
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.42 | |||||
| Equity-to-Asset | 0.82 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.1 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -7.4 | |||||
| 3-Year EPS without NRI Growth Rate | -6 | |||||
| 3-Year FCF Growth Rate | 5.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.47 | |||||
| 9-Day RSI | 39.99 | |||||
| 14-Day RSI | 41.31 | |||||
| 6-1 Month Momentum % | 163.93 | |||||
| 12-1 Month Momentum % | 2.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.91 | |||||
| Quick Ratio | 4.91 | |||||
| Cash Ratio | 4.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35.9 | |||||
| Shareholder Yield % | 0.88 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -65.1 | |||||
| ROA % | -55.95 | |||||
| ROIC % | -150.6 | |||||
| ROC (Joel Greenblatt) % | -227.88 | |||||
| ROCE % | -65.44 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.11 | |||||
| Price-to-Tangible-Book | 2.11 | |||||
| EV-to-EBIT | -1.82 | |||||
| EV-to-Forward-EBIT | -1.8 | |||||
| EV-to-EBITDA | -1.95 | |||||
| EV-to-Forward-EBITDA | -1.8 | |||||
| EV-to-Forward-Revenue | 98.48 | |||||
| EV-to-FCF | -2.31 | |||||
| Price-to-Net-Current-Asset-Value | 3.65 | |||||
| Price-to-Net-Cash | 3.99 | |||||
| Earnings Yield (Greenblatt) % | -54.95 | |||||
| FCF Yield % | -30.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TNYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tenaya Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.67 | ||
| Beta | 0 | ||
| Volatility % | 140.85 | ||
| 14-Day RSI | 41.31 | ||
| 14-Day ATR ($) | 0.332185 | ||
| 20-Day SMA ($) | 4.503 | ||
| 12-1 Month Momentum % | 2.44 | ||
| 52-Week Range ($) | 1.66 - 8.0914 | ||
| Shares Outstanding (Mil) | 78.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tenaya Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tenaya Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tenaya Therapeutics Inc Frequently Asked Questions
What is Tenaya Therapeutics Inc(TNYA)'s stock price today?
The current price of TNYA is $4.31. The 52 week high of TNYA is $8.09 and 52 week low is $1.66.
When is next earnings date of Tenaya Therapeutics Inc(TNYA)?
The next earnings date of Tenaya Therapeutics Inc(TNYA) is 2024-05-10 Est..
Does Tenaya Therapeutics Inc(TNYA) pay dividends? If so, how much?
Tenaya Therapeutics Inc(TNYA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers